Kyverna ‘resetting conversation’ with 1-year miv-cel data as autoimmune CAR-T peers hit safety snags Read more 

Lilly puts up $100M, plus billions on the backend, to form 5-target deal with China's InnoCare Read more 

Enveda reaps $311M series E to feed ambition to become a ‘household name’ Read more 

Max Eldridge

Max has more than ten years in Life Sciences recruitment, He collaborates with executives to foster growth in Pharma, Biotech, CRO, TechBio, and Medical Device sectors​

Contractors

Timesheet Portal

Clients
Legal
Contact Us

Copyright © 2026 | Hlx Life Sciences

Go to Top